Lecture Details - Table of Contents
This activity is part of PER's Integrated Oncology Learning Series:
A Focus on Thoracic Malignancies
Sixth Annual Symposium on the Future of Lung Cancer
Release Date: December 13, 2009| Dec 5, 2009, Washington, DC
Table of Contents
Impact of Histology on Response and Patient Selection
Nathan A. Pennell
Debate: Early Second-line Therapy/Maintenance Therapy Is Standard of Care - Pro
H. Jack West
Debate: Early Second-line Therapy/Maintenance Therapy Is Standard of Care - Con
Nasser H. Hanna
Optimizing EGFR Inhibition in Lung Cancer
Lecia V. Sequist
New Indications for Antiangiogenic Agents
David R. Spigel
Multidisciplinary Management of Locoregional NSCLC
Todd Demmy
David S. Ettinger
Quynh-Thu Le
Management of Metastatic NSCLC: Markers, Selection of Therapy, Maintenance Therapy, Supportive Care
Todd Demmy
David S. Ettinger
Quynh-Thu Le
New Systemic Therapies in Locally Advanced NSCLC
Ramaswamy Govindan
Surgery in Locally Advanced NSCLC
Frank C. Detterbeck
Inhibiting EML4-ALK in Lung Cancer
Alice Tsang Shaw
Novel Disruptors of Tumor Vasculature
David R. Spigel
Inhibiting Histone Deacetylases
Suresh Ramalingam
mTOR Inhibitors
Bruce E. Johnson
IGF-1R Inhibitors
Corey Langer
HSP90 Inhibitors
Scott N. Gettinger
Instructions for Participation
To view the streaming Flash Video lectures, click the "Listen to the Presentation" link. The latest version of Flash Player is recommended to view the Flash video.
Click here to download Flash Player >>
To download Podcast-ready movies, click "Download the Presentation," and select "Save target as..." The latest version of Quicktime is recommended to view these movies.
Click here to download Quicktime >>
Read all of the conditions in the Activity Terms box below. You must accept the Activity Terms in order to continue:
Disclaimer
Physicians’ Education Resource presents this resource for educational purposes only. Participants are expected to use their own expertise and judgment while engaged in the practice of medicine. Please consult full prescribing information for any drugs or procedures discussed within.
The views and opinions expressed in these presentations are those of the authors and do not necessarily reflect the views of the sponsor, supporter, or publisher. Although great care has been taken in compiling and checking the information given in this publication to ensure accuracy, the authors and Physicians’ Education Resource and its servants or agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions, or inaccuracies in this publication, whether arising from negligence or otherwise howsoever or for any consequences arising therefrom.
Disclosure of Unlabeled Uses
This reference may contain discussion of published and/or investigational uses of agents that are not approved by the US Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physician’s Desk Reference.
All rights reserved; for personal use only. No part of this presentation may be translated, reproduced or transmitted by any means or in any type of media form including electronic, mechanical photocopying, recording, broadcasting, or otherwise without prior permission from the publisher.
Software Requirements
The Web pages and Web-based applications require a minimum Web browser of Microsoft Internet Explorer 5.5 or higher, Mozilla Firefox 1.0 or higher, or another compatible Web browser.
If you are not sure of the version of your browser, select Help in the menu bar of your browser, then select About.
PC UsersIf you need to upgrade your Web browser, follow one of the links listed below:
- Microsoft Internet Explorer Downloads (Outside Source)
- Mozilla Firefox Product Page (Outside Source)
- Adobe Flash Player 9 (Outside Source)
- ITunes for Podcast (Outside Source)
- Adobe Acrobat Reader (Outside Source)
Macintosh Users
Compatible Web browsers include
- Firefox (Outside Source)
- Apple Safari (Outside Source).
- Adobe Flash Player 9 (Outside Source)
- ITunes for Podcast (Outside Source)
- Adobe Acrobat Reader (Outside Source)
110-2213
Educational Grants
An educational grant for this activity was provided by:
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Eli Lilly and Company
- Genentech BioOncology/
OSI Oncology - Merck Oncology
- Agennix, Inc.
- Novartis Oncology